Compare INLF & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INLF | AIMD |
|---|---|---|
| Founded | 2016 | 1984 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.6M | 10.2M |
| IPO Year | 2025 | N/A |
| Metric | INLF | AIMD |
|---|---|---|
| Price | $0.43 | $1.76 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 77.7K | 19.4K |
| Earning Date | 09-29-2025 | 03-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $19,332,282.00 | $113,037.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 33.11 | ★ 178.19 |
| 52 Week Low | $0.42 | $1.61 |
| 52 Week High | $21.00 | $4.50 |
| Indicator | INLF | AIMD |
|---|---|---|
| Relative Strength Index (RSI) | 27.04 | 38.05 |
| Support Level | $0.43 | $1.72 |
| Resistance Level | $0.45 | $1.90 |
| Average True Range (ATR) | 0.03 | 0.09 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 0.96 | 15.36 |
INLIF Ltd, through its subsidiary, is engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms. In addition, it offers installation and warranty services for manipulator arms, and accessories and raw materials for manipulator arms. The company portfolio includes injection molding machine-dedicated manipulator arms, including transverse single and double-axis manipulator arms, transverse and longitudinal multi-axis manipulator arms, and large bullhead multi-axis manipulator arms.
Ainos Inc is a dual-platform AI and biotech company pioneering smelltech and immune therapeutics. Its AI Nose platform and smell language model (SLM) digitize scent into Smell ID, a machine-readable data format, powering intelligent sensing across robotics, smart factories, and healthcare. The company also develops VELDONA, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases. It combines AI and Nose, redefining machine perception for the sensory age.